Ensign Peak Advisors Inc Sells 160 Shares of Ingevity Co. (NYSE:NGVT)

Ensign Peak Advisors Inc trimmed its stake in shares of Ingevity Co. (NYSE:NGVT – Get Rating) by 1.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,295 shares of the company’s stock after selling 160 shares during the quarter. Ensign Peak Advisors Inc’s holdings in Ingevity were worth $927,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Ronald Blue Trust Inc. grew its position in Ingevity by 1,548.3% during the 3rd quarter. Ronald Blue Trust Inc. now owns 478 shares of the company’s stock worth $31,000 after acquiring an additional 449 shares during the last quarter. Quadrant Capital Group LLC lifted its holdings in Ingevity by 1,694.3% in the 3rd quarter. Quadrant Capital Group LLC now owns 628 shares of the company’s stock worth $38,000 after buying an additional 593 shares during the period. Wipfli Financial Advisors LLC purchased a new stake in Ingevity in the 3rd quarter worth approximately $53,000. EMC Capital Management lifted its holdings in Ingevity by 49.3% in the 2nd quarter. EMC Capital Management now owns 2,031 shares of the company’s stock worth $128,000 after buying an additional 671 shares during the period. Finally, Point72 Hong Kong Ltd purchased a new stake in Ingevity in the 3rd quarter worth approximately $173,000. 90.01% of the stock is currently owned by institutional investors.

Insider Activity at Ingevity

In related news, SVP Richard Allen White, Jr. sold 1,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $81.00, for a total transaction of $116,559.00. Following the completion of the transaction, the senior vice president now owns 6,530 shares of the company’s stock, valued at approximately $528,930. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, SVP Richard Allen White, Jr. sold 1,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $81.00, for a total transaction of $116,559.00. Following the completion of the transaction, the senior vice president now owns 6,530 shares of the company’s stock, valued at approximately $528,930. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Stuart Edward Jr. Woodcock sold 4,968 shares of the firm’s stock in a transaction that occurred on Thursday, March 2nd. The shares were sold at an average price of $82.14, for a total value of $408,071.52. Following the transaction, the executive vice president now directly owns 26,541 shares of the company’s stock, valued at approximately $2,180,077.74. The disclosure for this sale can be found here. Insiders sold a total of 15,254 shares of company stock valued at $1,247,519 in the last 90 days. Corporate insiders own 0.71% of the company’s stock.

Ingevity Trading Down 5.4 %

NGVT opened at $71.42 on Monday. The stock has a market cap of $2.65 billion, a PE ratio of 13.03 and a beta of 1.83. The company has a quick ratio of 1.13, a current ratio of 2.24 and a debt-to-equity ratio of 2.11. The business has a 50 day moving average of $82.16 and a 200-day moving average of $73.99. Ingevity Co. has a 52 week low of $58.44 and a 52 week high of $90.81.

Ingevity (NYSE:NGVT – Get Rating) last released its earnings results on Monday, February 27th. The company reported $0.57 EPS for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.33). The firm had revenue of $383.60 million during the quarter, compared to analysts’ expectations of $395.77 million. Ingevity had a net margin of 12.68% and a return on equity of 34.63%. The company’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.78 EPS. Equities research analysts predict that Ingevity Co. will post 6.44 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on NGVT shares. Loop Capital upgraded Ingevity from a “hold” rating to a “buy” rating and increased their price objective for the stock from $81.00 to $100.00 in a report on Thursday, February 2nd. Wells Fargo & Company increased their price objective on Ingevity from $76.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 1st. Finally, StockNews.com cut Ingevity from a “buy” rating to a “hold” rating in a report on Wednesday, March 1st. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.67.

Ingevity Company Profile

(Get Rating)

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats.